共查询到19条相似文献,搜索用时 171 毫秒
1.
2.
中国乌头之研究 ⅩⅨ 四川雪上一枝蒿中生物碱及其结构 总被引:4,自引:0,他引:4
从四川金沙江畔雪上一枝蒿(Aconitum pendulum)中分出四个结晶性的生物碱,证明其中三个为已知生物碱,即次乌头碱(hypaconitine),乌头碱(aconitine)和3-乙酰乌头碱(3-acetylaconitine);另一种为新生物碱,暂称为雪乌碱(penduline)熔点166~167℃,分子式C34H47NO9,结构式初步推定如下式所示。雪上一枝蒿中主要生物碱为乌头碱,得率约为0.14%;雪乌碱对动物具有镇痛局麻等作用。 相似文献
3.
从赣皖乌头(Aconitum finetianum Hand-Mazz)中又分得五个生物碱,经光谱及化学方法鉴定,其中二个为新的二萜类生物碱,即脱乙酰冉乌头碱(N-deacetylranconitine),C30H42N2O6,熔点125~127℃,和脱乙酰赣乌碱(N-deacetylfinaconitine),C30H42N2O9,熔点121~123℃,及三个已知生物碱,即阿娃乌头碱(avadharidine)、牛扁次碱(lycoctonine)和脱乙酰刺乌头碱(N-deacetyllappaconitine)。经药理试验表明,脱乙酰冉乌头碱,脱乙酰赣乌碱和脱乙酰刺乌头碱均具有良好的镇痛效果。 相似文献
4.
目的建立HPLC法测定口服制川乌提取物后大鼠体内乌头类生物碱的方法。方法用Waters 2690@996 PAD系统,Halsil 100 C18柱(250 mm×4.6 mm ID, 5 μm),水-甲醇-二乙胺(75∶25∶0.1)为流动相,流速0.9 mL·min-1,检测波长240 nm。结果乌头碱在心脏、脾脏、肺脏、肾脏的线性范围:0.4-100 μg·mL-1,r分别为0.997 2,0.998 6,0.999 3,0.999 4;在肝脏的线性范围:2-200 μg·mL-1,r为0.999 0。次乌头碱在心、肝、脾、肺、肾、脑和脊髓的线性范围:5-100 μg·mL-1,r分别为0.999 4,0.999 7,0.999 8,0.998 4,0.999 8,0.999 8和0.999 7。乌头碱及次乌头碱的检测限(S/N=3)为0.4 μg·mL-1。各组织中的回收率:乌头碱为88.7%-102.2%,次乌头碱为865%-101.3%。结论本法为确证乌头类生物碱的中毒提供了科学有效的依据。 相似文献
5.
反相离子对色谱法测定附子中生物碱成分 总被引:6,自引:1,他引:6
目的测定附子中乌头碱、新乌头碱、次乌头碱、北乌碱、苯甲酰乌头原碱和苯甲酰新乌头原碱等6种生物碱的含量。方法用反相离子对HPLC法,使用AichromBond-1 C18柱(250 mm×4.6 mm ID);流动相:乙腈-5 mmol·L-1 NaH2PO4溶液,磷酸调至pH 4.5(50∶50),内含7 mmol·L-1 十二烷基硫酸钠(SDS);检测波长:235 nm;流速:1.0 mL·min-1;柱温:35 ℃。结果以上6种生物碱可以完全分离,准确测定。结论该方法准确度高,可应用于附子中生物碱的含量测定。 相似文献
6.
目的:建立小活络丸中生物碱成分乌头碱、次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰次乌头原碱与苯甲酰新乌头原碱的含量测定方法,以完善其质量标准。方法:采用高效液相色谱法, 选择PICKERING C18(4.6 mm×250 mm,5μm)色谱柱,以甲醇、乙腈和0.1%磷酸水为流动相,梯度洗脱,流速1.0 mL·min-1,柱温25 ℃,检测波长232 nm,进样量15 μL。结果:乌头碱、次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰次乌头原碱及苯甲酰新乌头原碱分别在各自范围内线性关系良好(r=0.9999),平均加样回收率分别为99.8%(RSD=0.8%)、99.9%(RSD=1.0%)、100.6% (RSD=1.4%)、100.8%(RSD=1.5%)、100.9%(RSD=1.5%)、100.6%(RSD=0.8%)。5批样品中上述6个成分含量范围分别为0.5~2.9、5.4~27.4、0.5~10.5、18.8~24.6、18.8~30.2及142.4~181.6 μg·g-1。 结论:所建立的同时测定6个生物碱含量的测定方法可准确测定小活络丸中生物碱成分的含量,有助于提高小活络丸的质量标准。 相似文献
7.
8.
两个新的双去甲二萜生物碱高乌宁碱丁和高乌宁碱戊的结构研究 总被引:7,自引:0,他引:7
目的:研究高乌头Aconitum sinomontanum Nakai根的化学成分。方法:采用硅胶柱色谱及离心薄层色谱分离化学成分,IR, 1HNMR, 13CNMR, 1H-1H COSY, HMBC, HMQC, MS等方法进行结构鉴定。结果:得到两个双去甲二萜生物碱高乌宁碱丁(sinomontanine D, 1)和高乌宁碱戊(sinomontanine E, 2)。结论:化合物1,2为新的双去甲二萜生物碱。 相似文献
9.
目的 通过全细胞膜片钳实验,从心肌电生理层面探索丹红注射液(DHI)治疗乌头碱诱导心律失常的可能机制。方法 基于人诱导多能干细胞衍生心肌细胞(hiPSC-CMs)膜片钳技术,即时给药并观察乌头碱不同浓度(3、9、27 μmol·L-1)对钠通道、hERG钾通道的抑制效果,进行造模条件的筛选;设置对照组、模型组(乌头碱1 μmol·L-1长时间造模)、DHI (3、9、27 μL·mL-1)组,乌头碱与DHI同时加药,记录动作电位幅度(APA)、放电频率、动作电位幅度下降50 %时的时程(APD50)和动作电位幅度下降90 %时的时程(APD90),并以对照组为标准,计算相对值;设置对照组、模型组、DHI (3 μL·mL-1)组,乌头碱与DHI同时加药,观察3~5 min,记录钠离子、hERG钾离子、钙离子电流密度。结果 给予即时药物处理,3、9、27 μmol·L-1的乌头碱对钠电流的抑制率分别为17.94 %、31.07 %、60.67 %,对hERG通道的抑制率分别为5.02 %、10.59 %、28.59 %;在短期内给乌头碱对hERG通道的抑制效果较为有限,而实际实验中,长时间的高浓度乌头碱孵育使钠电流被完全抑制,导致离子通道功能受损,因此选择乌头碱1 μmol·L-1长时间给药制备模型。与对照组比较,模型组hiPSC-CMs相对APA、相对APD50和相对APD90显著下降(P<0.01、0.001),相对放电频率显著升高(P<0.001);钠电流在一定时间内减小,抑制率为30.18 %;hERG钾电流明显减小,抑制率为72.33 %;钙电流明显增大,电流增大191.35 %。与模型组比较,DHI 3、9、27 μL·mL-1组相对放电频率显著降低(P<0.05、0.001)、相对APD90显著升高(P<0.05、0.01),3 μL·mL-1组相对APD50显著升高(P<0.001);DHI组钠电流、hERG钾电流的减小及钙电流的增大均有一定缓解。结论 DHI可能可以通过影响钠、钾、钙通道来缓解乌头碱导致的心律失常现象。 相似文献
10.
目的 考察乌头碱配伍人参皂苷Rb1、甘草苷后对HepG2药物代谢酶(Cytochrome P450,CYP450)中3A4亚型的报告基因荧光活性、mRNA转录及蛋白翻译水平的影响。方法 将pGLuc-CYP3A4报告基因质粒与pcDNA3.1-hPXR表达质粒共转染HepG2细胞,检测乌头类生物碱、人参皂苷和甘草的单体成分对CYP3A4的激活效应;并利用实时荧光定量PCR(qRT-PCR)及Western blotting技术检测人参皂苷Rb1、甘草苷与乌头碱对CYP3A4 mRNA及蛋白水平的影响。结果 报告基因模型检测结果显示,与对照组比较,乌头碱、新乌头碱、次乌头碱和乙酰乌头碱能下调CYP3A4报告基因荧光强度(P<0.05),其中乌头碱下调能力最强,人参皂苷Rb1、Rc、Re、Rg1以及甘草苷、异甘草苷、甘草素和甘草酸均能上调报告基因的荧光强度(P<0.05、0.01),其中人参皂苷Rb1和甘草苷上调能力最明显;同时乌头碱能下调CYP3A4 mRNA与蛋白表达水平(P<0.05、0.01),人参皂苷Rb1和甘草苷能逆转乌头碱下调CYP3A4的能力(P<0.05、0.01)。结论 人参皂苷Rb1、甘草苷与乌头碱配伍后可上调CYP3A4的表达,减少乌头碱在体内蓄积时间,起到减毒的作用。 相似文献
11.
12.
13.
本文研究了在不同pH的底液中,一些生物碱(乌头碱、小蘖碱、番木鳖减、辛可宁、白屈菜碱、那可汀、奎宁)与四苯硼钠间反应条件,观察了二者形成沉淀的关系.通过试验,提出在进行生物碱滴定时,根据生物碱的碱性强弱,可计算出底液适宜的pH,并提出以四苯硼钠滴定生物碱的安培方法. 相似文献
14.
海南萝芙木季胺碱化学成分的研究 总被引:1,自引:0,他引:1
从海南萝芙木生产“降压灵”的母液,经盐析得到生物碱部分,用硅胶柱层,制备薄层和葡聚糖凝胶过滤法,分得六种生物碱。碱Ⅰ(ajmaline)、碱Ⅱ(vellosimine)、碱Ⅲ(spegatrine)、碱Ⅳ(verticillatine)为已知碱,碱Ⅴ和碱Ⅵ为两个新的二聚体生物碱。根据红外、紫外、质谱、氢谱及碳谱等光谱分析,推定碱Ⅴ的化学结构为1式,命名为双斯配加春(dispegatrine)。并用半合成方法进一步确证了其结构.碱Ⅵ的结构待定.药理研究表明碱Ⅴ和碱Ⅵ均具有α-肾上腺素能受体阻断作用。 相似文献
15.
Angela Ameri 《Naunyn-Schmiedeberg's archives of pharmacology》1998,357(6):585-592
In the present study the effects of the two Aconitum alkaloids 14-benzoyltalitasamine and talitasamine on neuronal activity were investigated in order to obtain further insight
into structure-dependent effects of this group of alkaloids on central nervous activity. Both alkaloids are closely related
to aconitine, the main alkaloid of plants of Aconitum species. However, they have shortened side chains at position C3 and C8 of the molecule. The experiments were performed as
extracellular recordings of orthodromically and antidromically evoked population spikes as well as of field excitatory potentials
(EPSPs) from the CA1 region of rat hippocampal slices. 14-Benzoyltalitasamine exerted a reversible inhibition of the field
potentials in a concentration-dependent manner. The orthodromic population spike was attenuated at concentrations higher than
1 μM, while the field EPSP was already affected at a concentration of at least 0.3 μM. Both responses were completely blocked
at a concentration of 30 μM. The alkaloid failed to affect the presynaptic fiber spike at concentrations less than 10 μM.
There was only a up to 30% decrease in the antidromic population spike (10–100 μM). The inhibition of the antidromic spike
was increased by using a higher stimulus frequency. In contrast to 14-benzoyltalitasamine, the alkaloid talitasamine which
is lacking the benzoylester side chain was a less effective inhibitor of the orthodromic population spike and even failed
to affect the antidromic spike. Furthermore, the effects of the alkaloids on experimentally induced epileptiform activity
was examined. While talitasamine was lacking any significant effect at concentrations less than 100 μM, 14-benzoyltalitasamine
reversibly reduced both stimulus-triggered epileptiform activity in area CA1 elicited by omission of Mg2+ from the bathing medium as well as spontaneously occurring epileptiform activity in CA3 elicited by omission of Mg2+ and elevation of K+ to 5 or 8 mM. The antiepileptiform efficacy of this compound was concentration-dependent (0.3–10 μM) and manifested itself
as a decrease in burst frequency as well as in burst amplitude and was significantly increased by the higher K+ concentration.
Received: 25 August 1997 / Accepted: 15 February 1998 相似文献
16.
露蕊乌头的二萜生物碱 总被引:7,自引:0,他引:7
从露蕊乌头(Aconitum gymnandrum Maxim)中分离到11个二萜生物碱,利用光谱方法确定结构,证明其中一个为新生物碱,命名为露乌定,其余10个分别鉴定为14-乙酰基-8-O-甲基-塔拉胺(tal-atisamine,Ⅱ)、acoforine(Ⅲ)、非洲防己碱(columbidine,Ⅳ)、乌头碱(aconitine,Ⅴ)、ranaeonitine(Ⅵ)、塔拉定(talatizidine,Ⅶ)、异塔拉定(isotalatizidine.Ⅷ)、露乌碱(gymanaconitine,Ⅸ)、塔拉胺(talatisamine,Ⅹ)和阿替辛盐酸盐(atisine.HCl)。其中碱Ⅱ为首次在自然界中发现,碱Ⅲ~Ⅶ为首次从该植物中分离得到。 相似文献
17.
U. T. Gutser J. Friese J. F. Heubach T. Matthiesen N. Selve B. Wilffert J. Gleitz 《Naunyn-Schmiedeberg's archives of pharmacology》1997,357(1):39-48
Extracts of the plant Aconitum spec. are used in traditional Chinese medicine predominantly as anti-inflammatory and analgesic agents, the latter allegedly
equally potent as morphine but without any habit-forming potential. As the only pharmacologically active compounds, the C19 diterpenoid alkaloid aconitine, and some of its derivatives, have been proven to be antinociceptive in different analgesic
assays, but the mode of action is unknown. To elucidate the mode of action, ten aconitine-like derivatives were investigated
with respect to their affinity for voltage-dependent Na+ channels, the action on synaptosomal Na+ and Ca2+ homoeostasis and their antinociceptive, arrhythmogenic and acute toxic properties. Since aconitine is known to bind to site
II of Na+ channels, we determined the affinity of the aconitine-like derivatives in vitro to synaptosomal membranes by the [3H]-batrachotoxinin-binding assay and their properties on intrasynaptosomal concentrations of free Na+ and Ca2+ ([Na+]i and [Ca2+]i), both the latter determined fluorometrically with SBFI and Fura-2 respectively. Furthermore, the alkaloids’ arrhythmogenic
potential was investigated in guinea-pig isolated atria and the antinociceptive action on formalin-induced hyperalgesia and
the acute toxic action estimated in mice. The results show that the alkaloids could be divided into at least three groups.
The first is characterized by a high affinity to the site II of Na+ channels (K
i about 1.2 μM), the ability to enhance [Na+]i and [Ca2+]i (EC50 about 3 μM), a strong arrhythmogenic action that starts at about 30 nM, an antinociceptive effect (ED50 about 0.06 mg/kg) and high acute toxicity (LD50 values about 0.15 mg/kg). To this group belong aconitine, 3-acetylaconitine and hypaconitine. The second group, with lappaconitine
as the only member, has an affinity to Na+ channels an order of magnitude lower (K
i = 11.5 μM), less acute toxicity (LD50 about 5 mg/kg), and a two orders of magnitude lower antinociceptive action (ED50 about 2.8 mg/kg) and lower cardiotoxicity (bradycardia observed at 3 μM). Additionally, lappaconitine suppresses the increase
in [Ca2+]i of aconitine-stimulated synaptosomes and increases the excitation threshold of left atria, indicating an inhibition of Na+ channels. The other derivatives, i.e. delcorine, desoxydelcorine, karakoline, lappaconidine, lappaconine and lycoctonine,
belong to the third group, which has hardly any effects. They have a low affinity to Na+ channels with K
i values in the millimolar range, show no effect on synaptosomal [Na+]i and [Ca2+]i, no arrhythmogenic potential up to 100 μM, no antinociceptive activity and low toxicity with LD50 values greater than 50 mg/kg. For the investigated alkaloids we suggest two different antinociceptive-like modes of action.
Aconitine, hypaconitine and 3-acetylaconitine may induce a block of neuronal conduction by a permanent cell depolarisation,
whereas lappaconitine might act like local anaesthetics. However, because of the low LD50/ED30 quotients of 2–6, the antinociceptive-like action of the Aconitum alkaloids seems to reflect severe intoxication rather than a specific antinociceptive action. The structure/activity relationship
shows that alkaloids that activate or block Na+ channels have a benzoyl ester side chain in the C-14 or C-4 positions respectively, whereas the other compounds lack this
group.
Received: 24 June 1997 / Accepted: 8 September 1997 相似文献
18.